196 related articles for article (PubMed ID: 16300304)
1. [Risks and risk factors of blood transfusion].
Pihkala U
Duodecim; 2005; 121(19):2125, author reply 2125. PubMed ID: 16300304
[No Abstract] [Full Text] [Related]
2. Risks of virus transmission associated with animal sera or substitutes and methods of control.
Eloit M
Dev Biol Stand; 1999; 99():9-16. PubMed ID: 10404870
[No Abstract] [Full Text] [Related]
3. [Prevention of transfusion-associated viral infection].
Kojima K; Togashi T
Rinsho Byori; 2003 Feb; Suppl 124():121-6. PubMed ID: 12710042
[No Abstract] [Full Text] [Related]
4. Residual risks of blood transfusion in Rhode Island.
Sweeney JD; Kurtis J; Starakiewicz J
Med Health R I; 2005 Jul; 88(7):224-5, 228-31. PubMed ID: 16184827
[No Abstract] [Full Text] [Related]
5. [Transfusion of blood and products derived from blood].
Wautier JL
Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
[No Abstract] [Full Text] [Related]
6. Transfusion safety: Where are we today?
Luban NL
Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681
[TBL] [Abstract][Full Text] [Related]
7. The role of leukodepletion in the control of transfusion-transmitted disease.
Goldman M; Delage G
Transfus Med Rev; 1995 Jan; 9(1):9-19. PubMed ID: 7719040
[No Abstract] [Full Text] [Related]
8. [Infection control safety in blood transfusions].
Gargouri J; Brunot A; Souissi T
Tunis Med; 1993 Feb; 71(2):63-70. PubMed ID: 8322423
[No Abstract] [Full Text] [Related]
9. [Blood transfusion safety].
Koistinen J
Duodecim; 2004; 120(7):902-4. PubMed ID: 15154312
[No Abstract] [Full Text] [Related]
10. [Immunological aspects of blood transfusion preparations].
Matinlauri I
Duodecim; 2004; 120(7):867-75. PubMed ID: 15154308
[No Abstract] [Full Text] [Related]
11. Transfusion reactions due to Yersinia enterocolitica.
Whelen JK
Semin Perioper Nurs; 2000 Jan; 9(1):37-41. PubMed ID: 10818963
[TBL] [Abstract][Full Text] [Related]
12. [Special features of blood transfusion to children].
Salonvaara M
Duodecim; 2004; 120(7):860-5. PubMed ID: 15154307
[No Abstract] [Full Text] [Related]
13. [Blood and plasma transfusion in the treatment of acute blood loss].
Hiippala S
Duodecim; 2004; 120(7):893-901. PubMed ID: 15154311
[No Abstract] [Full Text] [Related]
14. [Artificial blood in the future].
Charles E
Rev Infirm; 1999 Sep; (52):42-3. PubMed ID: 10723430
[No Abstract] [Full Text] [Related]
15. Prevention of infectious disease transmission by blood and blood products.
Aronson DL; Menaché D
Prog Hematol; 1987; 15():221-41. PubMed ID: 3140296
[No Abstract] [Full Text] [Related]
16. Pathogen reduction technologies: what are the concerns?
AuBuchon JP
Vox Sang; 2004 Jul; 87 Suppl 2():84-9. PubMed ID: 15209887
[No Abstract] [Full Text] [Related]
17. Bloodless cardiac surgery: not just possible, but preferable.
Putney LJ
Crit Care Nurs Q; 2007; 30(3):263-70. PubMed ID: 17579310
[TBL] [Abstract][Full Text] [Related]
18. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations.
Székely A; Cserép Z; Sápi E; Breuer T; Nagy CA; Vargha P; Hartyánszky I; Szatmári A; Treszl A
Ann Thorac Surg; 2009 Jan; 87(1):187-97. PubMed ID: 19101294
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-transmitted infectious diseases.
Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
[TBL] [Abstract][Full Text] [Related]
20. [Application of pre- and post-transfusion virological controls prior to the suppression of their recommendation].
Petit H; Laperche S; Lefrère JJ
Transfus Clin Biol; 2006 Oct; 13(4):246-52. PubMed ID: 16829151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
